Globitair

ASN: los inhibidores del SGLT2 benefician a los mayores con enfermedad renal crónica

Infobae AmericasSpain

ASN: los inhibidores del SGLT2 benefician a los mayores con enfermedad renal crónica

Healthday Spanish

Read the full story at Infobae AmericasOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about Spain